| Detected | Trial | Change |
|---|---|---|
| 2026-08-13 | NCT05635643 Study of CHS-114 in Participants With Advanced Solid Tumors |
Enrollment closed, study ongoing |
| 2026-08-13 | NCT05635643 Study of CHS-114 in Participants With Advanced Solid Tumors |
Trial sites reduced: 16 -> 12 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06457503 | A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With… | Nasopharyngeal Cancer Recurrent | Recruiting |
| Phase 2 | |||
| NCT06679985 | A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants… | Hepatocellular Carcinoma | Active, Not Recruiting |
| Phase 1 | |||
| NCT06657144 | A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments… | Metastatic Solid Tumor | Recruiting |
| NCT06389526 | A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors | Advanced or Metastatic Solid Tumors | Not Yet Recruiting |
| NCT05635643 | Study of CHS-114 in Participants With Advanced Solid Tumors | Advanced Solid Tumor | Active, Not Recruiting |